BeStock  
Stocks › Biotechnology › SVRA

Savara SVRA

US equityMarket cap rank #3206Biotechnology
$4.26 −$0.95 (-18.23%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.30 +0.94%
Open$4.19
Prev close$5.21
Day range$4.00 – $4.52
Volume17.08M
Market cap$939.86M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership82.1%-4.65 pts vs. prior quarter
Institutions holding206-3 vs. prior quarter
Insider trades (recent)23 buys / 23 sellsBalanced
Short interest15.71% of floatDays to cover 12.9 · as of 30 Oct 2026
Short-sale volume share17.5%5-day average of daily volume

Short-sale volume as % of daily volume

11%20%29%39%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$4.18M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$4.2MSuper+$59.3KBig−$709.1KMid−$4.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 30.8% of shares outstanding.

Largest holders

  • New Enterprise Associates, Inc.9.09%
  • Bain Capital Life Sciences Investors, LLC6.54%
  • VR Management, LLC5.48%
  • Deerfield Management Company, L.P.5.04%
  • BlackRock4.67%
  • TCG Crossover Management, LLC4.59%
  • Frazier Life Sciences Management, LP3.61%
  • Polar Capital Holdings Plc3.54%

By investor type

  • VC/PE Fund31.95%
  • Mutual Fund26.26%
  • Hedge Fund22.30%
  • Individual/Insider1.98%
  • Public Company0.78%
  • Private Company0.47%
  • Government Pension Fund0.13%
  • Insurance Company0.11%

Reported short interest has fallen from 18.74% to 15.71% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Dcf Advisers, Llc Mutual Fund 2026/Q3 +570,000 0.2%
FMR Mutual Fund 2026/Q3 +331,105 0.2%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +261,291 1.5%
BMO Asset Management Mutual Fund 2026/Q3 +244,366 0.1%
Jane Street Group, LLC Private Company 2026/Q3 +206,903 0.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +188,815 3.0%
UBS Asset Management Mutual Fund 2026/Q3 +187,882 0.3%
Silverarc Capital Management, LLC Hedge Fund 2026/Q3 +163,374 0.6%
Y-Intercept (Hong Kong) Limited Mutual Fund 2026/Q3 +154,456 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +203,505 0.1%
OrbiMed Advisors LLC VC/PE Fund 2026/Q3 +3,324,900 1.5%
Marshall Wace LLP Hedge Fund 2026/Q3 +1,742,641 2.3%
BlackRock Mutual Fund 2026/Q3 +1,203,313 4.9%
VR Management, LLC VC/PE Fund 2026/Q3 +1,005,568 5.5%
Pictet Asset Management Limited Mutual Fund 2026/Q3 +487,674 1.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
23 Sep 2026 Braden Parker Chief Commercial Officer Sale to Issuer -29,323 $5.07 55,677
14 Jul 2026 Robert Lutz Chief Financial Officer Other Acquisition +35,000 – 135,000
14 Jul 2026 Robert Lutz Chief Financial Officer Other Derivative Acquisition +70,000 $5.81 70,000
21 Jun 2026 David Lowrance Former Chief Financial & Administrative Officer and Secretary Derivative Exercise and Sale -580,187 $5.68 436,032
17 Mar 2026 David Lowrance Former Chief Financial & Administrative Officer and Secretary Derivative Exercise and Sale -116,760 $5.04 436,032
17 Mar 2026 David Lowrance Former Chief Financial & Administrative Officer and Secretary Derivative Exercise and Retained +249,987 $4.45 436,032
15 Feb 2026 Joseph S. McCracken Lead Independent Director Derivative Exercise and Retained +1,807 $1.76 262,644
18 Dec 2025 David Ramsay Independent Director Open Market Disposition -20,000 $6.06 2,493,642
17 Dec 2025 David Ramsay Independent Director Intent to Sell (Form 144) -20,000 $6.11 –
15 Dec 2025 David Lowrance Former Chief Financial & Administrative Officer and Secretary Other Disposition -32,000 – 186,045
15 Dec 2025 Matthew Pauls Chairperson & CEO Other Disposition -128,995 – 788,050
13 Dec 2025 David Lowrance Former Chief Financial & Administrative Officer and Secretary Sale to Issuer -62,960 $6.92 186,045
13 Dec 2025 Matthew Pauls Chairperson & CEO Sale to Issuer -195,705 $6.92 788,050
13 Dec 2025 Robert Lutz Chief Financial Officer Sale to Issuer -67,760 $6.92 193,977
13 Dec 2025 Anne Erickson Chief Business & Corporate Affairs Officer Sale to Issuer -62,960 $6.92 271,712
13 Dec 2025 Kate McCabe Chief Legal Officer Sale to Issuer -39,350 $6.92 519,232
9 Dec 2025 Matthew Pauls Chairperson & CEO Other Disposition -23,629 – 662,750
8 Dec 2025 David Ramsay Independent Director Other Acquisition +40,000 – 80,000
8 Dec 2025 Joseph S. McCracken Lead Independent Director Other Acquisition +40,000 – 80,000
8 Dec 2025 Richard Hawkins Independent Director Other Acquisition +40,000 – 80,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 32,273,605 15.7% 12.9
15 Oct 2026 28,737,897 14.0% 12.2
30 Sep 2026 43,563,969 21.2% 17.2
15 Sep 2026 43,343,616 21.1% 36.3
31 Aug 2026 41,426,996 20.2% 24.3
14 Aug 2026 38,505,948 18.7% 27.1

Discussion

No comments yet — be the first to weigh in on SVRA.

Sign in to join the discussion.

Scroll to Top